title: Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device.
abstract: There is an 80-90% mortality rate within the first 2 months of the occurrence of a post-infarction ventricular septal defect (VSD) with medical treatment alone. The muscular VSD presents a technical problem for the surgeon. Surgical treatment was unsuccessful in two patients. They were treated successfully using the Amplatzer Septal Occluder, with improvement in their condition.
authors.affiliation: Department of Pediatrics, Lund University Hospital, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Pesonen
authors.forename: U
authors.initials: U
authors.lastname: Thilen
authors.forename: S
authors.initials: S
authors.lastname: Sandström
authors.forename: H
authors.initials: H
authors.lastname: Arheden
authors.forename: B
authors.initials: B
authors.lastname: Koul
authors.forename: S E
authors.initials: SE
authors.lastname: Olsson
authors.forename: R F
authors.initials: RF
authors.lastname: Wilson
authors.forename: C
authors.initials: C
authors.lastname: Toher
authors.forename: A
authors.initials: A
authors.lastname: Bank
authors.forename: J
authors.initials: J
authors.lastname: Bass
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D001241:Aspirin; D006328:Cardiac Catheterization / Q000295:instrumentation* / Q000379:methods; D005500:Follow-Up Studies; D006345:Heart Septal Defects, Ventricular / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D019919:Prosthesis Implantation / Q000295:instrumentation / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D010959:Tissue Plasminogen Activator; D001241:Aspirin